Listen to the article
Aetna Inc. has reached a settlement agreement of $117.7 million to resolve allegations that it violated the False Claims Act by submitting false diagnosis codes for Medicare beneficiaries and failing to correct them once discovered, according to sources familiar with the matter.
The settlement, finalized this week, marks one of the larger healthcare fraud resolutions of the year and comes after a lengthy investigation by federal authorities into the insurance giant’s Medicare billing practices.
The Department of Justice had alleged that Aetna, one of the nation’s largest health insurance providers, knowingly submitted inaccurate diagnosis codes to the Centers for Medicare & Medicaid Services (CMS). These codes, which are used to determine risk-adjusted payments to Medicare Advantage organizations, allegedly resulted in significant overpayments to the company.
Federal investigators claimed the insurer not only submitted these erroneous codes but also failed to implement adequate compliance measures to identify and correct them once internal audits revealed discrepancies. This alleged double violation heightened the severity of the case against the company.
The settlement does not include an admission of wrongdoing by Aetna, which has maintained throughout the investigation that its coding practices were consistent with industry standards and CMS guidelines. However, the substantial payment reflects the seriousness of the allegations and the potential penalties the company might have faced had the case gone to trial.
Medicare Advantage plans, also known as Medicare Part C, have come under increasing scrutiny in recent years as the program has grown to cover approximately 30 million Americans. These plans receive payments from the federal government based on the health status of their members, with higher payments for patients with more serious medical conditions—creating potential incentives for coding inflation.
“This settlement underscores our commitment to protecting the integrity of the Medicare program,” said a Justice Department official who requested anonymity because they were not authorized to speak publicly about the case. “When insurers submit false information to increase their payments, it diverts critical resources away from the program and ultimately harms taxpayers.”
The case against Aetna is part of a broader government crackdown on Medicare Advantage fraud. Several other major insurers, including UnitedHealth Group and Humana, have faced similar investigations in recent years, with some resulting in substantial settlements.
Healthcare fraud experts note that the $117.7 million settlement, while significant, represents only a fraction of Aetna’s annual revenue from its Medicare business. The company, which merged with CVS Health in a $69 billion deal in 2018, manages Medicare coverage for millions of seniors nationwide.
As part of the settlement agreement, Aetna has reportedly agreed to implement enhanced compliance measures, including improved oversight of its diagnostic coding practices and regular independent audits of its Medicare Advantage claims.
Consumer advocacy groups have welcomed the settlement but argue that it highlights systemic issues within the Medicare Advantage program that require legislative reform.
“While financial penalties are important, they don’t address the fundamental problems with how risk adjustment works in Medicare Advantage,” said a spokesperson for a healthcare consumer rights organization. “The current system creates perverse incentives for insurers to focus more on documentation than on actual patient care.”
The settlement comes at a time when federal healthcare programs are under increasing financial pressure, with Medicare’s trust fund projected to face insolvency within the next decade without significant reforms.
Industry analysts suggest that the resolution of this case might prompt other insurers to review their own compliance programs and potentially set aside reserves for similar settlements, as federal authorities continue to prioritize healthcare fraud enforcement.
The settlement must still receive final approval from the court, which is expected in the coming weeks. Aetna will likely make the payment to the federal government by the end of the second quarter of 2026.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
7 Comments
While it’s positive to see this settlement, I hope the government continues to aggressively pursue cases of healthcare fraud. Taxpayer money should be protected, and providers need to be held accountable for any abuse of the system.
This case highlights the complexity of Medicare billing and the need for robust compliance programs. Insurers must have the proper controls in place to catch and correct errors before they become larger issues.
A $117.7 million settlement is significant. I wonder what specific steps Aetna will take to improve its internal controls and compliance going forward. Transparency around these changes could help rebuild trust in the industry.
Submitting inaccurate codes that lead to overpayments is a serious issue. I’m glad to see federal authorities investigating these claims and reaching a substantial settlement. Insurers need to be held accountable for any fraudulent billing practices.
This case raises questions about the extent of the problem with improper Medicare billing. How widespread are these issues across the industry? Stronger oversight and penalties may be needed to deter future violations.
You make a good point. Widespread billing issues could undermine the integrity of the entire Medicare system. Regulators should investigate further to ensure compliance is improved industry-wide.
This settlement highlights the importance of accurate Medicare billing practices. Aetna’s alleged submission of false diagnosis codes and failure to correct them is concerning. It’s critical that insurers maintain robust compliance measures to ensure the integrity of the Medicare system.